Clinical Trial

Switching From Xiidra to TRYPTYR

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated December 5, 2025 (before its estimated April 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
To determine the efficacy of switching participants who are being treated with Xiidra to acoltremon 0.003%. Hypothesis: Switching to acoltremon 0.003% will greatly improve the signs and symptoms of participants who were being treated with Xiidra at 28 days post-treatment compared to baseline.
Trial Details
NCT Number NCT07267481
Lead Sponsor Southern College of Optometry
Conditions Dry Eye, Dry Eyes Chronic, Dry Eye Syndromes, Eye Diseases
Enrollment 100 participants
Start Date 2025-12-15
Primary Completion 2026-04-15 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-05